Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<H Shrs>HSI Closes Up 95 Pts, Led by Pharma; CSPC PHARMA Spikes ~14%
Recommend 2 Positive 0 Negative 0 |
||||
|
||||
|
The HSI inched up 95 points or 0.4% to close at 24,951. The HSCEI added 63 points or 0.8% to close at 8,453. The HSTECH picked up 16 points or 0.3% to close at 4,778. Total market turnover for the day amounted to $263.081 billion. Several blue chips announced their results. CITIC (00267.HK)'s full-year net profit rose 0.9% with higher final dividend, but its share price ebbed 0.2%. LONGFOR GROUP (00960.HK) reported a 90% drop in full-year net profit and a core loss of RMB1.7 billion, and its stock price lost 3.7%. MEITUAN-W (03690.HK)'s management forecasted that 1Q26 core local commerce business loss would be halved, yet its share price slipped 0.9%. SMIC (00981.HK) reported a 9% increase in full-year net profit, but its stock price faded 1.2%. CHINA MOBILE (00941.HK) recorded a 0.9% decline in full-year net profit and increased its final dividend. Its stock lifted 0.7%. HAIER SMARTHOME (06690.HK) posted a 4.4% increase in full-year net profit and planned to spend RMB3-6 billion to repurchase A-shares, denting its share price by 4.1%. PING AN (02318.HK) reported a 7% YoY increase in annual net profit, while brokers anticipated its CSM may turn positive this year. Its share price jumped up 2%. CNOOC (00883.HK) reported a 12% decline in full-year net profit, dragging down its stock price by 0.5%. Pharma generally inclined. CSPC PHARMA (01093.HK)'s Chairman, Cai Dongchen, increased stake by 49.4 million shares worth $413 million on market yesterday (26th), boosting its stock price by 13.8%. INNOVENT BIO (01801.HK) reported its first full-year profit, and its share price swelled 7.7%. SINO BIOPHARM (01177.HK)'s full-year underlying profit rose 31%, and its share price gained 1.2%. 3SBIO (01530.HK) and DUALITYBIO-B (09606.HK) surged 10.4% and 11%, while SIMCERE PHARMA (02096.HK) and HENGRUI PHARMA (01276.HK) rallied 8% and 7.8%. SKB BIO-B (06990.HK), REMEGEN (09995.HK), BEONE MEDICINES (06160.HK) and JUNSHI BIO (01877.HK) escalated 6-7.1%. AASTOCKS Financial News Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
